| Bioactivity | 5-Iodo-2’-β-C-methyl cytidine is a purine nucleoside analogue. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis, induction of apoptosis, etc[1]. |
| Name | 5-Iodo-2’-β-C-methyl cytidine |
| CAS | 2072145-60-7 |
| Formula | C10H14IN3O5 |
| Molar Mass | 383.14 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Robak T, Robak P. Purine nucleoside analogs in the treatment of rarer chronic lymphoid leukemias. Curr Pharm Des. 2012;18(23):3373-88. |
5-Iodo-2’-β-C-methyl cytidine
CAS: 2072145-60-7 F: C10H14IN3O5 W: 383.14
5-Iodo-2’-β-C-methyl cytidine is a purine nucleoside analogue. Purine nucleoside analogs have broad antitumor activity
Data collection：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.